Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy and safety of quetiapine fumarate
(SEROQUEL) in the treatment of adolescent patients with schizophrenia and bipolar I disorder.